Testing effectiveness (Phase 2)Ended earlyNCT01740401
What this trial is testing
CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma
Who this might be right for
Melanoma
Icahn School of Medicine at Mount Sinai 10